Olsson, Sven-Eric <br/><br/>
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.  [electronic resource] 

 -  Human vaccines  Oct 2009 
 - 696-704 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1554-8619 
<br/><br/><label>Standard No.: </label>10.4161/hv.5.10.9515  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Viral--blood<br/>Cervix Uteri--cytology<br/>Female<br/>Follow-Up Studies<br/>Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18<br/>Humans<br/>Papillomavirus Infections--epidemiology<br/>Papillomavirus Vaccines--adverse effects<br/>Placebos--administration & dosage<br/>Vulva--pathology<br/>Young Adult